Імуноцитохімічне (HBME-1, ТПО) та цитохімічне (ДАП IV) дослідження після ТАПБ вузлів щитоподібної залози

В. Г. Хоперія

doi:10.24026/1818-1384.3(32).2010.96402

Автор(и)

В. Г. Хоперія Український науково-практичний центр ендокринної хірургії, трансплантації ендокринних органів і тканин МОЗ України, Київ, Україна

DOI:

https://doi.org/10.24026/1818-1384.3(32).2010.96402

Ключові слова:

immunocytochemistry TPO, HBME-1, cytochemistry DAP IV, markers of malignancy, thyroid cytology

Анотація

It was reported previously that more precise diagnosis of thyroid cancer could be achieved if, in addition to cytological diagnosis on FNA smears, reliable markers for thyroid malignancy were used. A recent immunohistochemistry study was demonstrated that the antigen recognized by HBME-1 has a stronger expression in malignant than benign thyroid tumors in both surgical and FNA cell blocks. The present study is aimed not only to validate the role of HBME-1, but rather to establish the combination of the thyroid peroxidase immunocytochemistry with MoAb 47, HBME-1 and DAP IV staining on FNA specimens of thyroid nodule. The analysis was performed on FNA samples from 111 thyroid tumors: The diagnostic sensitivity of TPO staining was 100%, its specificity 92,8%. The sensitivity of DAP IV staining was less for diagnosis of malignancy was 69,2%, its specificity 91,5%. Despite of overall sensitivity 98% of HBME-1, it was only 44% specific. HBME-1 is a sensitive marker of thyroid carcinoma. However, using of TPO immunostaining and detection of DAP IV activity can be increases the level of sensitivity of thyroid cytology without decreasing its specificity.

Біографія автора

В. Г. Хоперія, Український науково-практичний центр ендокринної хірургії, трансплантації ендокринних органів і тканин МОЗ України, Київ

V. Khoperia

Посилання

Aratake Y., Kotani T., Tamura K., Araki Y., Kuribayaschi T., Konoe K., Ohtaki S. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases // Am. J. Clin. Pathol. — 1992. — Vol. 96. — P. 306–310. https://doi.org/10.1093/ajcp/96.3.306

Baloch Z.W., Fleisher S., LiVolsi V.A., Gupta P.K. Diagnosis of ‘follicular neoplasm’: a gray zone in thyroid fine-needle aspiration cytology // Diagn. Cytopathol. — 2002. — Vol. 26. — P. 41–44. https://doi.org/10.1002/dc.10043

Cheung C.C., Ezzat S., Freeman J.L., Rosen I.B. Asa S.L. Immunohistochemical diagnosis of papillary thyroid carcinoma // Mod. Pathol. — 2001. — Vol. 14. — P. 338–342. https://doi.org/10.1038/modpathol.3880312

Christensen L., Blichert-Toft M., Brandt M., Lange M., Sneppen S.B., Ravnsbaek J., Mollerup C.L., Strange L., Jensen F., Kirkegaard J., Hansen H.S., Sorensen S.S., Feldt-Rasmussen U. Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule // Clin. Endocrinol. — 2000. — Vol. 53. — P. 161–169. https://doi.org/10.1046/j.1365-2265.2000.01035.x

Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Sherman S.I., Tuttle R.M. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce // Thyroid. — 2006. — Vol. 16. — P.109–142. https://doi.org/10.1089/thy.2006.16.109

De Micco C., Carayon P., Conte Devolx B., Denizot A., Henry J. Thyroid peroxidase (TPO) immunocytochemistry as a screening test for malignancy in thyroid cytology: a prospective evaluation in 1620 resected thyroid nodules // J. Endocrinol. Invest. — 1998. — Vol. 21. – Suppl. 4. — P. 5.

De Micco C., Ruf J., Chrestian M., Gros N., Henry J.F., Carayon P. Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissue // Cancer. — 1991. — Vol. 67. — P. 3036–3041. https://doi.org/10.1002/1097-0142(19910615)67:12<3036::aid-cncr2820671218>3.0.co;2-d

De Micco C., Vasko V., Garcia S., Zoro P., Denizot A., Henry J. Fineneedle aspiration of thyroid follicular neoplasms: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47 // Surgery. — 1994. — Vol. 116. — P. 1031–1035.

De Micco C., Vassko V., Henry J.F. The value of thyroid peroxidase immunohistochemistry for preoperative fine-needle aspiration diagnosis of the follicular valiant of papillary thyroid cancer // Surgery. — 1999. — Vol. 126. — P. 1200–1204. https://doi.org/10.1067/msy.2099.101428

De Micco C., Zoro P., Garcia S., Skoog L., Tani E., Carayon P., Henry J.F. Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine needle biopsy // Eur. J. Endocrinol. — 1994. — Vol. 131. — P. 474–479. https://doi.org/10.1530/eje.0.1310474

Faroux M.J., Theobald S., Pluot M., Patey M., Menzies D. Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration // Pathol. Res. Pract. — 1997. — Vol. 193. — P. 705–712. https://doi.org/10.1016/s0344-0338(97)80030-1

Ito Y., Yoshida H., Tomoda C., Miya A., Kobayashi K., Matsuzuka F., Kakudo K., Kuma K., Miyauchi A. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma // Anticancer Res. — 2005. — Vol. 25. — P. 179–182.

Miettinen M., Karkkainen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumors. Preferential reactivity with malignant tumors // Virchows Arch. — 1996. — Vol. 429. — P. 213–219. https://doi.org/10.1007/bf00198336

Papotti M., Rodriguez J., De Pompa R., Bartolazzi A., Rosai J. Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential // Mod. Pathol. — 2005. — Vol. 18. — P. 541–546. https://doi.org/10.1038/modpathol.3800321

Raab S.S., Vrbin C.M., Grzybicki D.M., Sudilovsky D., Balassanian R., Zarbo R.J., Meier F.A. Errors in thyroid gland fine-needle aspiration // Am. J. Clin. Pathol. — 2006. — Vol. 125. — P. 873–882. https://doi.org/10.1309/7rqe37k6439t4pb4

Sack M.J., Astengo-Osuna C., Lin B.T., Battifora H., LiVolsi V.A. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma // Mod. Pathol. — 1997. — Vol. 10. — P. 668–674.

Saggiorato E., De Pompa R., Volante M., Cappia S., Arecco F., Dei Tos A.P., Orlandi F., Papotti M. Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application // Endocr. Relat. Cancer. — 2005. — Vol. 12. — P. 305–317. https://doi.org/10.1677/erc.1.00944

Vasko V., Gaudart J., Allasia C., Savchenko V., Di Cristofaro J., Saji M., Ringel M.D., De Micco C. Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma // Eur. J. Endocrinol. — 2004. — Vol. 151. — P. 779–786. https://doi.org/10.1530/eje.0.1510779

Zoro P., Vasko V., Garcia S., Pazart L., Aho S., De Micco C. Marqueurs de malignite ́ dans le cytodiagnostic des nodules thyroidiens. Re ́ve ́lation de l’activite ́ dipeptidyl aminopeptidase IV (DAP IV) // Ann. Pathol. — 1996. — Vol. 16. — P. 261–265.